Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Novartis image

Novartis eye drug succeeds in Phase III trial

August 16, 2012
Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA

Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …

News
novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012
Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …

News
Roche image

Roche posts strong sales results

July 27, 2012
Sales and Marketing Pegasys, Perjeta, Roche, Zelboraf, dalcetrapib

Roche has published healthy revenue growth for the first half of 2012, but its profits have taken a hit. The …

News
Avastin image

Lucentis price cut ends PCT-Novartis dispute

July 26, 2012
Sales and Marketing ABPI, NHS, PCTs, Roche, SHIP Cluster, avastin

An NHS body has been persuaded to reverse its policy of recommending Avastin for wet AMD. The Southampton, Hampshire, Isle …

News
erbitux image

Erbitux fails in gastric cancer trial

July 6, 2012
Research and Development, Sales and Marketing Erbitux, Merck Serono, Roche, failure, gastric cancer

Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …

News
Avastin pack shot

NICE no for Avastin in breast cancer

July 6, 2012
Sales and Marketing NICE, Roche, avastin, breast cancer, rejection

NICE has decided once again not to recommend Roche’s Avastin on the NHS for the first line treatment of metastatic …

News
FDA image

FDA clears Arena and Eisai’s obesity drug

June 28, 2012
Sales and Marketing Arena, Belviq, Eisai, FDA, Qnexa, Roche, obesity

Eisai and Arena’s Belviq has gained FDA approval, making it the first obesity drug to be approved in over ten …

News
Tarceva image

NICE final yes for Zytiga and Tarceva

June 27, 2012
Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga

In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News
Roche image

Roche’s Perjeta increases survival

June 27, 2012
Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …

News
Roche image

Roche earmarks $300m for diagnostics HQ

June 26, 2012
Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing

Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …

News
roche_glass_building

Roche failed to investigate 80,000 safety incidents

June 25, 2012
Manufacturing and Production, Sales and Marketing EMA, MHRA, Roche, pharmacovigilance

The European Medicines Agency is investigating Roche after ‘deficiencies’ in the manufacturer’s pharmacovigilance processes came to light. It has emerged …

News
Roche image

Roche signs research deal on autism spectrum disorders

June 19, 2012
Research and Development, Sales and Marketing ASD, FXS, Roche, Seaside Therapeutics, asperger's, autism

Roche has signed an agreement with Seaside Therapeutics to develop new treatments for autism and other neurodevelopmental conditions such as …

News
Zelboraf image

Roche’s Zelboraf rejected by NICE

June 15, 2012
Sales and Marketing Cancer, Dillon, NICE, Roche, Zelboraf, melanoma

NICE is not recommending Roche’s targeted melanoma pill Zelboraf because of its high cost and uncertainties over its survival benefit. …

News

FDA approves Roche’s breast cancer drug

June 11, 2012
Sales and Marketing EMA, FDA, Perjeta, Roche, breast cancer

US regulators have approved Roche’s new breast cancer drug after granting it a priority review to speed up the process. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025